Global Continuous Glucose Monitoring Systems Market — Analysis and Forecast (2016-2022)

Global Continuous Glucose Monitoring Systems Market — Analysis and Forecast (2016-2022)

  • November 2016 •
  • 190 pages •
  • Report ID: 4717470 •
  • Format: PDF
Global Continuous Glucose Monitoring Systems market is expected to grow over $2.13 billion by 2022

The gradual advancement and innovation of new diabetic care technologies have formed a concrete platform for the further growth of Continuous Glucose Monitoring (CGM) Systems market. With the emergence of advanced technologies such as mobile health, smart sensors, wearable technologies, and 3D-printing into the field of diabetic care, there has been a rise in the overall demand of the newly developed CGM devices.Presently, the focus of the government initiativeis mainly towardsdeveloping non-invasive solutions, controlling the level of increase in diabetic population, and integrating advanced technologies to fulfill the unmet needs of the diabetic population.

Governmental regulations and standards are playing a major role in sustaining the growth and development of the CGM Systems market. The main aim of these regulations is to make the device moreadaptable and attentive towards different types of diabetic conditions as well as to provide modern mobile technologies to the diabetic population. The patientsbenefit indirectly through these regulations as it helps them to save time and cuts-down the overall cost of monitoring devicesas the patients receive the required treatment for the disease.

The market growth is propelled due to factors such as: increasing demand for non-invasive treatments, technological innovation and advancements, increasing diabetic population, and Medicare & reimbursement policies, among others.

This study includes an overview and analysis of the CGM Systems market, by components end user groups, applications, and geography, allowing the research to develop a comprehensive outlook of the market. The market report presents a detailed and analytical study of the entire market and provides a comprehensive insight into various forms of developments, trends and key participants. The type of diabetes are categorized into three major categories, viz. type 1, type 2, and gestational in the report. All of the above mentioned report coverage parametersarediscussed across different regions such asNorth America, Europe, Asia Pacific (APAC), and Rest of the World (ROW).

While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, associations, and regulatory bodies, and their involvement in the CGM Systems market.

The answers to the following key questions can be found in the report:
- What are the major drivers, challenges and opportunities of the CGM Systems market and their use cases?
- How is the blood glucose monitoring device market evolving?
- What are the driving and restraining factors in the blood glucose monitoring device market?
- What are the market shares of the leading segments of the CGM Systems market in 2015?
- How will each component of the CGM Systems grow over the forecast period and how much revenue will these account for in 2022?
- How will the market shares of the leading national markets change by 2022 and which country will lead the market in 2022?
- How the industry will evolve during the period between 2016 and 2022?
- What are the key developmental strategies implemented in different applications across all regions?
- How will the key market players leverage on key developments such as mergers & acquisitions, partnerships, and product launches among others?
- Which geographical region will lead the global CGM Systems market by the end of the forecast period?
- Who are the key players in the CGM Systems market?
- What are different end user groups in this market and how are they categorized?
- What are the different applications in which CGM devices are being used?
- What are the different used case scenarios considered under different applications?
- What are the market trends and key developments in different geographical regions?

The research study tries to answer various aspects of the CGM Systems market with the help ofcentral factors driving the market, threats that can possibly slow down the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The studytakes into account Porter’s Five Force model and opportunity matrix for an in-depth study of the CGM Systems market and an assessment of the factors governing the same.

Executive Summary
The growth of the diabetic care market is attributed majorly to the rapid increase in the diabetic population, integration of smart devices with medical devices and advancement of healthcare technologies. The gradual advancement and innovation of new diabetic care technologies are developing a concrete platform for further growth of diabetic care market.

The increasing demand for Continuous Glucose Monitors(CGM), Self-Blood Glucose Monitors(SBGM), and insulin delivery devices has created the opportunity for manufacturers to develop more cost effective and advanced devices.CGM devices offer regular blood glucose measurements and provide advance solutions to the patients. The demand for CGM devices are increasing every year due to its ease of access and facility.The global Continuous Glucose Monitoring (CGM) Systems market has been identified as one of the fastest growing industries, owing to the changing dynamics of the legal and regulatory framework and the intense competitive rivalry among a plethora of public companies.

High prevalence of diabetes in many countries, specifically countries having low- and middle-income. This high prevalence of Type 2 diabetes can be controlled by following simple life measures such as indulging in lots of physical activities, avoiding fast and junk food, and retaining normal body weight, among others. It has been analyzed that the people under the age of 50-60 belonging to middle and low income countries are more prone to have diabetes as compared to people of other age groups. While, in high income countries, people over the age of 60 holds more casesof diabetes.

The global CGM Systems market is expected to grow at a CAGR of 24.10% from 2016 to 2022 and reach a figure of $2.13 billion by 2022. The advancements in technology, ease of use, smart device connectivity are some of the major driving factors for this market. The global CGM Systems market has been classified on the basis of component, end user group, application and geography.

Sensors generated the maximum revenue at an estimated CAGR of 24.60% from 2016 to 2022. The durability of sensors, its affordable cost, and miniaturization are factors supporting the market growth.
The integration of insulin pumps in CGM systems and emerging artificial pancreas technology exhibits insulin pumps as the fastest growing segment at a CAGR of 24.80% during the forecast period. The installment of a transmitter and a receiver is a onetime process and hence the cost incurred is very low which results in low market value.

Diabetes affects all age groups and hence the need for CGM Systems are increasing with the growing awareness and adoption of the device. The end user group is divided on the basis of patient’s age and their complications. In this report the end user group are categorized as Children & Teens, Youth, and Middle Aged & Aged.

The end applications of the CGM systems can be seen in Home, Hospitals, Clinics, and Diagnostics Centers. Household or Home setting application have dominated the market in 2015 and growing at a CAGR of 24.70% from 2016 to 2022.
North America dominated the global market in 2015 with a share of 46% due to the increasing adoption of CGM devices for better healthcare management. APAC, holds the highest number of diabetic patients where a large number of developments in diabetic care have been noticed in the last few years. However, the APAC is estimated to show the highest growth with a CAGR of 26.32% from 2016 to 2022 specifically in the Middle East region.

The preventive measures and increasing awareness about diabetic complications are presumed to control the prevalence in the near future and thus, help in the reduction of premature mortality rates from non-communicable diseases by 2030. Many sectors of society have a role to play, including governments, employers, educators, manufacturers, civil society, private sector, the media and individuals themselves.